Olema Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Olema Pharmaceuticals, Inc. has filed 554 SEC EDGAR filings since 27 Aug 2018

SEC filing history

Showing 1-7 of 7 matching filings.

Per page
25
Current page
1
SC 13D/A File 005-91849

AMENDMENT NO. 3 TO SCHEDULE 13D

Filing date
04 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91849

SC 13D/A filing

Filing date
06 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91849

SC 13D/A filing

Filing date
28 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91849

AMENDMENT NO. 2 TO SCHEDULE 13D

Filing date
14 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91849

AMENDMENT NO. 1 TO THE SCHEDULE 13D

Filing date
02 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91849

SC 13D filing

Filing date
03 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91849

THE SCHEDULE 13D

Filing date
20 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .